Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes Without Cardiovascular Disease: A Danish Cohort Study
- 1 June 2020
- journal article
- research article
- Published by Elsevier BV in The American Journal of Medicine
- Vol. 133 (6), E269-E279
- https://doi.org/10.1016/j.amjmed.2019.10.042
Abstract
No abstract availableFunding Information
- Medtronic
- Pfizer
- Boehringer Ingelheim
- AstraZeneca
- Biotronik
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Bayer
This publication has 39 references indexed in Scilit:
- Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial InfarctionThe American Journal of Medicine, 2013
- Glomerular filtration rate and albuminuria predict mortality independently from coronary artery calcified plaque in the Diabetes Heart StudyCardiovascular Diabetology, 2013
- Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetesJournal of Diabetes and its Complications, 2012
- More Impact of Microalbuminuria on Retinopathy Than Moderately Reduced GFR Among Type 2 Diabetic PatientsDiabetes Care, 2012
- The Danish National Patient RegisterScandinavian Journal of Public Health, 2011
- The Danish Civil Registration SystemScandinavian Journal of Public Health, 2011
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific DeathThe New England Journal of Medicine, 2011
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesThe Lancet, 2010
- Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in DiabetesJournal of the American Society of Nephrology, 2009
- Proteinuria Predicts Stroke and Other Atherosclerotic Vascular Disease Events in Nondiabetic and Non–Insulin-Dependent Diabetic SubjectsStroke, 1996